Methylprednisolone Sodium Succinate
8 NDCs across 4 manufacturers|3 Generic,5 Brand
Methylprednisolone Sodium Succinate is used to treat adrenal insufficiency, asthma, berylliosis, brain neoplasms, ulcerative colitis and dermatitis herpetiformis, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved before 1982, and the first generic was approved Jan 1, 1982.
Methylprednisolone Sodium Succinate is available as 8 NDCs from 4 manufacturers (3 generic, 5 brand), with NADAC prices from $3.27 to $10.04 per EA — the most expensive product costs about 3.1× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
8
3G / 5B
Manufacturers
4
competing in market
Price Spread
$3.27 – $10.04
per EA
7d Activity
avg -6.7% WoW · of 8 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Pharmacia & Upjohn Company LLC manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Corticosteroid class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
4 manufacturers producing METHYLPREDNISOLONE SODIUM SUCCINATE
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
SOLU-MEDROL 125 MG VIAL | $10.0357 per EA | -0.15% |
SOLU-MEDROL 40 MG VIAL | $6.2813 per EA | — |
SOLU-MEDROL 40 MG VIAL | $6.2813 per EA | — |
SOLU-MEDROL 40 MG VIAL | $6.2813 per EA | — |
SOLU-MEDROL 125 MG VIAL | $5.2349 per EA | — |
METHYLPREDNISOLONE SS 125 MG | $3.2655 per EA | -8.90% |
METHYLPREDNISOLONE SS 125 MG | $3.2655 per EA | -8.90% |
METHYLPREDNISOLONE SS 125 MG | $3.2655 per EA | -8.90% |
Frequently Asked Questions
What is Methylprednisolone Sodium Succinate used to treat?
Methylprednisolone Sodium Succinate is used to treat adrenal insufficiency, asthma, berylliosis, brain neoplasms, ulcerative colitis and dermatitis herpetiformis, per the National Library of Medicine's MED-RT classification.
When did Methylprednisolone Sodium Succinate become available as a generic?
FDA approved the first generic Methylprednisolone Sodium Succinate (ANDA) on Jan 1, 1982.
How many Methylprednisolone Sodium Succinate products are on the market?
The Methylprednisolone Sodium Succinate drug market contains 8 NDCs from 4 manufacturers — 3 generic and 5 brand products.
What is the price range for Methylprednisolone Sodium Succinate?
NADAC reference prices for Methylprednisolone Sodium Succinate range from $3.2655 to $10.0357 per EA — the most expensive product costs about 3.1× the cheapest.
Is generic Methylprednisolone Sodium Succinate cheaper than brand?
The average generic NADAC for Methylprednisolone Sodium Succinate is $3.2655 per EA, versus $6.8229 for brand-labeled products — brand versions average about 2.1× the generic price.
Which manufacturers make Methylprednisolone Sodium Succinate?
4 manufacturers list Methylprednisolone Sodium Succinate in NADAC. Ranked by number of NDCs, the largest are Pharmacia & Upjohn Company LLC (5), Hikma Pharmaceuticals USA Inc. (1), Dr. Reddy's Laboratories Inc. (1), Fresenius Kabi USA, LLC (1).
How has the price of Methylprednisolone Sodium Succinate changed recently?
Over the past 7 days, 0 Methylprednisolone Sodium Succinate NDCs rose and 4 fell, with a market-wide average change of -6.7%.